Literature DB >> 21190754

Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection.

S Sethi, K W Garey, V Arora, S Ghantoji, P Rowan, M Smolensky, H L DuPont.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21190754     DOI： 10.1016/j.jhin.2010.09.024

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  9 in total

1.  Enteric glial cells are susceptible to Clostridium difficile toxin B.

Authors:  Katia Fettucciari; Pamela Ponsini; Davide Gioè; Lara Macchioni; Camilla Palumbo; Elisabetta Antonelli; Stefano Coaccioli; Vincenzo Villanacci; Lanfranco Corazzi; Pierfrancesco Marconi; Gabrio Bassotti
Journal:  Cell Mol Life Sci       Date:  2016-11-28       Impact factor: 9.261

2.  Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

Authors:  Gabrio Bassotti; Lara Macchioni; Lanfranco Corazzi; Pierfrancesco Marconi; Katia Fettucciari
Journal:  Cell Mol Life Sci       Date:  2017-12-28       Impact factor: 9.261

3.  Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole.

Authors:  Vy P Pham; Andrea M Luce; Sara C Ruppelt; Wenjing Wei; Samuel L Aitken; William L Musick; Ryan K Roux; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

4.  High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection.

Authors:  A Wadhwa; M F Al Nahhas; R A Dierkhising; R Patel; P Kashyap; D S Pardi; S Khanna; M Grover
Journal:  Aliment Pharmacol Ther       Date:  2016-07-22       Impact factor: 8.171

5.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

6.  Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge.

Authors:  Kelly R Reveles; Kierra M Dotson; Anne Gonzales-Luna; Dhara Surati; Bradley T Endres; M Jahangir Alam; Kevin W Garey
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

Review 7.  Role of gut pathogens in development of irritable bowel syndrome.

Authors:  Madhusudan Grover
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

8.  Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.

Authors:  Srishti Saha; Kanika Sehgal; Sumitabh Singh; Madhusudan Grover; Darrell Pardi; Sahil Khanna
Journal:  J Clin Gastroenterol       Date:  2022-02-01       Impact factor: 3.174

9.  Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire.

Authors:  Kevin W Garey; Samuel L Aitken; Liliane Gschwind; Sumana Goddu; Yang Xie; Catherine Duff; Frédéric Barbut; Dhara N Shah; Herbert L DuPont
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.